These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14770077)

  • 101. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD; Balfour JA
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Pharmacokinetics of azithromycin after single- and multiple-doses in children.
    Stevens RC; Reed MD; Shenep JL; Baker DK; Foulds G; Luke DR; Blumer JL; Rodman JH
    Pharmacotherapy; 1997; 17(5):874-80. PubMed ID: 9324176
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Assessment of the bioequivalence of different formulations containing azithromycin (tablets and suspension).
    Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
    Arzneimittelforschung; 2004 Sep; 54(9A):578-82. PubMed ID: 15497663
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Azithromycin: mechanisms of action and their relevance for clinical applications.
    Parnham MJ; Erakovic Haber V; Giamarellos-Bourboulis EJ; Perletti G; Verleden GM; Vos R
    Pharmacol Ther; 2014 Aug; 143(2):225-45. PubMed ID: 24631273
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Safety of azithromycin in pediatric infectious diseases: a clinical systematic review and meta-analysis.
    Li D; Wang Y
    Transl Pediatr; 2021 Oct; 10(10):2594-2601. PubMed ID: 34765483
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Randomized trial of azithromycin to eradicate Ureaplasma respiratory colonization in preterm infants: 2-year outcomes.
    Viscardi RM; Terrin ML; Magder LS; Davis NL; Dulkerian SJ; Waites KB; Allen M; Ajayi-Akintade A; Ambalavanan N; Kaufman DA; Donohue P; Tuttle DJ; Weitkamp JH
    Pediatr Res; 2022 Jan; 91(1):178-187. PubMed ID: 33658655
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Randomised trial of azithromycin to eradicate
    Viscardi RM; Terrin ML; Magder LS; Davis NL; Dulkerian SJ; Waites KB; Ambalavanan N; Kaufman DA; Donohue P; Tuttle DJ; Weitkamp JH; Hassan HE; Eddington ND
    Arch Dis Child Fetal Neonatal Ed; 2020 Nov; 105(6):615-622. PubMed ID: 32170033
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Self-Reported Side Effects following Mass Administration of Azithromycin to Eliminate Trachoma in Amhara, Ethiopia: Results from a Region-Wide Population-Based Survey.
    Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Chanyalew M; Melak B; Ayele Z; Gessese D; Ayenew G; Gashaw B; Tadesse Z; Callahan EK; Nash SD
    Am J Trop Med Hyg; 2019 Mar; 100(3):696-699. PubMed ID: 30675840
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Bronchiectasis in Children: Current Concepts in Immunology and Microbiology.
    Pizzutto SJ; Hare KM; Upham JW
    Front Pediatr; 2017; 5():123. PubMed ID: 28611970
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids.
    Zhao X; Jiang Z; Yang F; Wang Y; Gao X; Wang Y; Chai X; Pan G; Zhu Y
    PLoS One; 2016; 11(12):e0167032. PubMed ID: 27907030
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Use and safety of azithromycin in neonates: a systematic review.
    Smith C; Egunsola O; Choonara I; Kotecha S; Jacqz-Aigrain E; Sammons H
    BMJ Open; 2015 Dec; 5(12):e008194. PubMed ID: 26656010
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Antimalarial activity of tulathromycin in a murine model of malaria.
    Villarino N; Denny JE; Schmidt NW
    Antimicrob Agents Chemother; 2015; 59(6):3672-4. PubMed ID: 25870067
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia.
    Hassan HE; Othman AA; Eddington ND; Duffy L; Xiao L; Waites KB; Kaufman DA; Fairchild KD; Terrin ML; Viscardi RM
    J Clin Pharmacol; 2011 Sep; 51(9):1264-75. PubMed ID: 21098694
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Antimicrobial therapy in childhood asthma and wheezing.
    Simon A; Schildgen O
    Treat Respir Med; 2006; 5(4):255-69. PubMed ID: 16808545
    [TBL] [Abstract][Full Text] [Related]  

  • 115. [Use of azithromycin in the treatment of acute otitis media and tonsillopharyngitis: summary and conclusions.
    Klein JO; Schaad UB
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S140-1. PubMed ID: 14770078
    [No Abstract]   [Full Text] [Related]  

  • 116. Rationale for single and high dose treatment regimens with azithromycin.
    Gordon EM; Blumer JL
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S102-7. PubMed ID: 14770072
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.
    Block SL; Cifaldi M; Gu Y; Paris MM
    Clin Ther; 2005 Jun; 27(6):786-94. PubMed ID: 16117986
    [TBL] [Abstract][Full Text] [Related]  

  • 118. The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media.
    Biner B; Celtik C; Oner N; Küçükuğurluoğlu Y; Güzel A; Yildirim C; Adali MK
    Turk J Pediatr; 2007; 49(4):390-6. PubMed ID: 18246740
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update.
    Ruuskanen O
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S135-9. PubMed ID: 14770077
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.